CD8A and HIV infectious disease: Similar patterns have been reported in other viral settings, including the long‐term persistence of YFV‐specific TSCM with recall capacity decades after vaccination [12, 18] and the restoration of CD8+ TSCM frequencies during antiretroviral therapy in HIV infection, where higher levels correlated with improved immune control [15, 36].